Alnylam (ALNY) PT Cut to $137 at Needham & Company; Long-Term Investors Should Buy Weakness
Go back to Alnylam (ALNY) PT Cut to $137 at Needham & Company; Long-Term Investors Should Buy Weakness| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 251.65 +7.33 (3.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $244.32 | 52 Week High | $109.10 | |||
| Open | $246.86 | 52 Week Low | $31.38 | |||
| Day High | $255.51 | P/E | N/A | |||
| Day Low | $244.13 | EPS | $-1.45 | |||
| Volume | 1,131,950 | |||||
